Anti-oncogenic effects of tropomyosin: Isoform specificity and importance of protein coding sequences

被引:0
|
作者
Braverman, RH
Cooper, HL
Lee, HS
Prasad, GL
机构
[1] NCI,CELLULAR ONCOL LAB,BETHESDA,MD 20892
[2] NCI,TUMOR IMMUNOL & BIOL LAB,BETHESDA,MD 20892
关键词
tropomyosin; isoforms; tumor suppressor;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Suppression of muscle type isoforms of tropomyosin (TM) is a common biochemical event in malignantly transformed cells. To evaluate the role of TM proteins and isoform specificity in cellular transformation, cDNAs that consist of coding sequences of TM1 (product of beta gene) and TM2 (product of alpha gene), but lacking untranslated regions (UTRs), have been expressed separately in DT (v-Ki-ras transformed NIH3T3) cells, and elevated levels of the corresponding proteins were detected. DT cells which over express TM2 manifest growth in soft agar. Elevated levels of TM1 protein in DT cells resulted in flattened cell morphology and complete abolition of anchorage independent growth. Tumorigenesis in athymic nude mice was observed in the absence of transduced TM1 mRNA. Thus, expression of TM1 protein is sufficient for tumor suppression: the UTRs of TM1 are not required for the tumor suppressive effects. Expression of TM2 protein, on the other hand, has no effect on the transformed phenotype of DT cells. These data indicate that isoforms 1 and 2 of TMs perform distinct physiological roles.
引用
收藏
页码:537 / 545
页数:9
相关论文
共 49 条
  • [1] Oncogenic and Anti-Oncogenic Effects of Transient Receptor Potential Channels
    Liberati, Sonia
    Morelli, Maria Beatrice
    Nabissi, Massimo
    Santoni, Matteo
    Santoni, Giorgio
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (03) : 344 - 366
  • [2] N terminus is essential for tropomyosin functions - N-terminal modification disrupts stress fiber organization and abolishes anti-oncogenic effects of tropomyosin-1
    Bharadwaj, S
    Hitchcock-DeGregori, S
    Thorburn, A
    Prasad, GL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (14) : 14039 - 14048
  • [3] Anti-oncogenic activity of Src-Like Adaptor Protein signalization protein in colorectal cancers
    Naudin, C.
    Leroy, C.
    Sirvent, A.
    Simon, V.
    Bourgaux, J. F.
    Robert, B.
    Hollande, F.
    Roche, S.
    BULLETIN DU CANCER, 2010, 97 : S30 - S30
  • [4] Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells
    Ozgun, Gizem
    Yaras, Tutku
    Akman, Burcu
    Ozden-Yilmaz, Guelden
    Landman, Nick
    Karakulah, Gokhan
    van Lohuizen, Maarten
    Senturk, Serif
    Erkek-Ozhan, Serap
    CANCER GENE THERAPY, 2024, 31 (04) : 537 - 551
  • [5] EphrinA1 mediated anti-oncogenic effects are regulated by microRNA-122 in NSCLC cells
    Sukka-Ganesh, Bhagyalaxmi
    Mohammed, Kamal A.
    Kaye, Frederic
    Nasreen, Najmunnisa
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 1469 - 1479
  • [6] Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells
    Gizem Ozgun
    Tutku Yaras
    Burcu Akman
    Gülden Özden-Yılmaz
    Nick Landman
    Gökhan Karakülah
    Maarten van Lohuizen
    Serif Senturk
    Serap Erkek-Ozhan
    Cancer Gene Therapy, 2024, 31 : 537 - 551
  • [7] Global importance of RNA secondary structures in protein-coding sequences
    Fricke, Markus
    Gerst, Ruman
    Ibrahim, Bashar
    Niepmann, Michael
    Marz, Manja
    BIOINFORMATICS, 2019, 35 (04) : 579 - 583
  • [8] NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function
    Wang, YQ
    Cui, HJ
    Schroering, A
    Ding, JL
    Lane, WS
    McGill, G
    Fisher, DE
    Ding, HF
    NATURE CELL BIOLOGY, 2002, 4 (11) : 888 - 893
  • [9] NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function
    Yongqing Wang
    Hongjuan Cui
    Allen Schroering
    Jane L. Ding
    William S. Lane
    Gaël McGill
    David E. Fisher
    Han-Fei Ding
    Nature Cell Biology, 2002, 4 : 888 - 893
  • [10] Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells
    Zhao, Hongjuan
    Flamand, Vincent
    Peehl, Donna M.
    BMC MEDICAL GENOMICS, 2009, 2